Journals / İstanbul Tıp Dergisi / 2012 / Cilt: 13 - Sayı: 3

A rare cause of acid: Galactosemia

Nadir bir assit nedeni: Galaktozemi

Pages
145–148
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

For this reason, galac- tosemia should be kept in mind in the differential diagnosis of in patients with abdominal distention and ascites.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Galactosemia is an autosomal recessive disease of galactose metobolism.
📊
Key Findings & Data:Classic galactosemia is due to accumulation of toxic galactose metabolites after a homogenous or heterog- enous mutation in galactose-1-phosphate uridyltransferase gene.
💡
Conclusion & Impact:For this reason, galac- tosemia should be kept in mind in the differential diagnosis of in patients with abdominal distention and ascites.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Galactosemia is an autosomal recessive disease of galactose metobolism. Classic galactosemia is due to accumulation of toxic galactose metabolites after a homogenous or heterog- enous mutation in galactose-1-phosphate uridyltransferase gene. Galactose and its metabolites are very toxic to the liver, brain, lens, and kidneys. The most common symptoms of galactosemia are jaundice, vomiting, and hepatomegaly. However, in some rare cases, abdominal distension and acid may be an early symptom. Herein we present a case of galac- tosemia who presented with ascites and was diagnosed in the newborn period. A 26-day male patient was sent to our hospi- tal because of abdominal distension and ascites. He present- ed with failure to thrive, abdominal distention, and jaundice. Liver function test abnormality, mild tubulopathy, ascites, and cataract were found in his laboratory and physical exam- inations. The patient was diagnosed as galactosemia due to pozitive reductant substance in urine, Beutler test abnormal- ity, and decreased level of galactose-1-P uridiyltransferase enzyme level. Breast-feeding was discontinued and lactose free diet was started. For treatment of ascites, albumin infu- sion and diuretics were used. Patient responded well to the treatment and he is still in follow-up. Early diagnosis of ga- lactosemia is important since with diet disease can be taken under control and complications of sepsis, mental disorders, and failure to thrive can be prevented. For this reason, galac- tosemia should be kept in mind in the differential diagnosis of in patients with abdominal distention and ascites.

Özet

Galaktozemi, galaktoz metabolizmasının otozomal resesif bir hastalığıdır. Klasik galaktozemi, galaktoz-1-fosfat üridil transferaz (GALT) genindeki homozigot ya da heterozigot mutasyon sonucunda galaktoz metabolitlerinin toksikbirikimi ile oluşur. Galaktoz ve metabolitleri karaciğer, beyin, lens ve böbrekler için oldukça toksiktir. En sık klinikbulguları sarılık, kusma ve hepatomegalidir. Bununla birlikte nadiren bazolgularda karın şişliği ve assit erken belirti olarak görülebilir. Bu yazıda, assit nedeninin araştırılması amacı ile yönlendirilen ve galaktozemi tanısı konulan yenidoğan olgusu sunuldu. Yirmi altı günlük erkek olgubatın distansiyonu ve assit nedeniyle hastanemize gönderildi. Kilo alamama, karında şişlik ve sarılık şikayetleri olan olguda karaciğer fonksiyon bozukluğu, assit, hafif derecede tubulopati ve katarakt saptandı. Tetkiklerinde diğer metabolik taramalar normal iken, idrarda redüktan madde pozitifliği, Beutler testi bozukluğu ve eritrositlerde galakoz-1-p üridil transferaz enzim düzeyi düşük tespit edilen olguya galaktozemi tanısı konuldu. Tedavideannesütü kesildi, laktozsuz diyete geçildi. Assit tedavisialbümin infüzyonu ve diüretik ile yapıldı. Tedaviye iyi yanıt alındı ve halen hastanın izlemi sürmektedir. Galaktozeminin erken tanınması ile sepsis, mental bozukluklar, büyüme geriliği gibi komplikasyonların önlenmesi ve diyetle hastalığın kontrol altına alınabilmesi oldukça önemlidir. Bu nedenle karın şişiliği ve assitle başvuran olguların ayırıcı tanısında galaktozeminin akılda tutulması gerekir.

🔖

Cite This Article

HATİPOĞLU, N., AKINCI, N., GÜLEÇ, S. G., YÜKSEK, K., URGANCI, N. (2022). A rare cause of acid: Galactosemia. İstanbul Tıp Dergisi, Cilt: 13 - Sayı: 3, 145–148. https://ajindex.com/articles/552515

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Bosh AM. Classic galactosemia: dietary dilemmas. J Inherit Metab Dis 2011;34:257-60
  2. Feillet F, Merten M, Battaglia-Hsu SF, et al. Evidence of cataplerosis in a patient with neonatal classical ga- lactosemia presenting as citrin deficiency. J Hepatol 2008;48:517-22
  3. Bosch AM. Classical galactosaemia revisited. J Inherit Metab Dis 2006;29:516-25
  4. Bennett MJ. Galactosemia diagnosis gets an upgrade. Clin Chem 2010;56:690-2
  5. Rinaldo P, Matern D. Newborn screening for inherited metabolic disease. In: Hoffmann GF, Zschocke J, Ny- han WL, editors. Inherited metabolic diseases. New York: Springer; 2010. p. 252-53
  6. Shield JP, Wadsworth EJ, MacDonald A, et al. The re- lationship of genotype to cognitive outcome in galac- tosaemia. Arch Dis Child 2000;83:248-50
  7. Tyfield LA. Galactosaemia and allelic variation at the galactose-1-phosphate uridyltransferase gene: a com- plex relationship between genotype and phenotype. Eur J Pediatr 2000;159:204-7
  8. Elsas LJ. Galactosemia (Classic Galactosemia, GALT Deficiency, Galactose-1-Phosphate Uridyltransferase Deficiency. Includes: Variant Galactosemias). GeneR- 148 eviews [Internet]. Initial Posting: February 4, 2000; Last Update: October 26, 2010
  9. Shin YS. Galactose metabolites and disorders of ga- lactose metabolism. In: Hommes FA, ed. Techniques in diagnostic human biochemical genetics: a labora- tory manual. New York: Wiley-Liss; 1991. p. 267-83
  10. Rhode H, Elei E, Taube I, et al. Newborn screening for galactosemia: ultramicro assay for galactose-1- phosphate-uridyltransferase activity. Clin Chim Acta 1998;274:71-87
  11. Waggoner DD, Buist NR, Donnell GN. Long-term prognosis in galactosaemia: results of a survey of 350 cases. J Inherit Metab Dis 1990;13:802-18
  12. Herman R, Kunisaki S, Molitor M, et al. The use of peritoneal venous shunting for intractable neonatal as- cites: a short case series. J Pediatr Surg 2011;46:1651- 4
  13. Freer DE, Ficicioglu C, Finegold D. Newborn screen- ing for galactosemia: a review of 5 years of data and audit of a revised reporting approach. Clin Chem 2010;56:437-44
  14. Merritt RJ, Jenks BH. Safety of soy-based infant for- mulas containing isoflavones: the clinical evidence. J Nutr 2004;134:1220-1224S
  15. Turck D. Soy protein for infant feeding: what do we know? Curr Opin Clin Nutr Metab Care 2007;10:360-5.